
Structurally engineered furan fatty acids for the treatment of dyslipidemia and cardiovascular diseaseAward last edited on: 2/5/2024
Sponsored Program
SBIRAwarding Agency
NIH : NHLBITotal Award Amount
$299,169Award Phase
1Solicitation Topic Code
837Principal Investigator
Francisco Jose SchopferCompany Information
Furanica Inc
2731 Lillard Drive
Davis, CA 95618
Davis, CA 95618
N/A |
N/A |
N/A |
Location: Single
Congr. District: 04
County: Yolo
Congr. District: 04
County: Yolo
Phase I
Contract Number: 1R41HL167544-01A1Start Date: 5/1/2023 Completed: 4/30/2024
Phase I year
2023Phase I Amount
$299,169Public Health Relevance Statement:
Project Narrative Cardiovascular disease accounts for 30% of all deaths worldwide. The applicant proposes to advance novel fatty acid mimetics to manage 1) dyslipidemia, 2) glucose homeostasis, and 3) cardiovascular disease. The successful development of this class of novel fatty acids would greatly benefit those patients who are exposed to excessive residual cardiovascular risks.
Project Terms: